Literature DB >> 14718670

Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins.

Daniela Taverna1, Heather Moher, Denise Crowley, Lubor Borsig, Ajit Varki, Richard O Hynes.   

Abstract

Expression of alphavbeta3- or alphavbeta5-integrins and selectins is widespread on blood cells and endothelial cells. Here we report that human tumor cells injected s.c. into mice lacking beta3- or beta3/beta5-integrins or various selectins show enhanced tumor growth compared with growth in control mice. There was increased angiogenesis in mice lacking beta3-integrins, but no difference in structure of the vessels was observed by histology or by staining for NG2 and smooth muscle actin in pericytes. Bone marrow transplants suggest that the absence of beta3-integrins on bone marrow-derived host cells contributes to the enhanced tumor growth in beta3-null mice, although few, if any, bone marrow-derived endothelial cells were found in the tumor vasculature. Tumor growth also was affected by bone marrow-derived cells in mice lacking any one or all three selectins, implicating both leukocyte and endothelial selectins in tumor suppression. Reduced infiltration of macrophages was observed in tumors grown in mice lacking either beta3-integrins or selectins. These results implicate cells of the innate immune system, macrophages or perhaps natural killer cells, in each case dependent on integrins and selectins, in tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718670      PMCID: PMC321755          DOI: 10.1073/pnas.0307289101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  New aspects of natural-killer-cell surveillance and therapy of cancer.

Authors:  Mark J Smyth; Yoshihiro Hayakawa; Kazuyoshi Takeda; Hideo Yagita
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

Review 2.  Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

Authors:  Shahin Rafii; David Lyden; Robert Benezra; Koichi Hattori; Beate Heissig
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

Review 3.  Tumor-associated macrophages in breast cancer.

Authors:  Russell D Leek; Adrian L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 4.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.

Authors:  Shahin Rafii; David Lyden
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 5.  The diverse roles of integrins and their ligands in angiogenesis.

Authors:  R O Hynes; J C Lively; J H McCarty; D Taverna; S E Francis; K Hodivala-Dilke; Q Xiao
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

Review 6.  A reevaluation of integrins as regulators of angiogenesis.

Authors:  Richard O Hynes
Journal:  Nat Med       Date:  2002-09       Impact factor: 53.440

7.  Defective associations between blood vessels and brain parenchyma lead to cerebral hemorrhage in mice lacking alphav integrins.

Authors:  Joseph H McCarty; Rita A Monahan-Earley; Lawrence F Brown; Markus Keller; Holger Gerhardt; Kristofer Rubin; Moshe Shani; Harold F Dvorak; Hartwig Wolburg; Bernhard L Bader; Ann M Dvorak; Richard O Hynes
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.

Authors:  Sachie Hiratsuka; Kazuhiro Nakamura; Shinobu Iwai; Masato Murakami; Takeshi Itoh; Hiroshi Kijima; J Michael Shipley; Robert M Senior; Masabumi Shibuya
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

Review 10.  Tumors and inflammatory infiltrates: friends or foes?

Authors:  Claudio Brigati; Douglas M Noonan; Adriana Albini; Roberto Benelli
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  30 in total

1.  Conference report--tumor-host interactions: a complex network of signals. Highlights from the annual meeting of the American Society for Cell Biology; December 13-17, 2003; San Francisco, California.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-02-12

2.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

3.  Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Authors:  Jason A Bush; Hideki Kitaura; Yuliang Ma; Steven L Teitelbaum; F Patrick Ross; Jeffrey W Smith
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

4.  Cooperation between VEGF and beta3 integrin during cardiac vascular development.

Authors:  Sara M Weis; Jeffrey N Lindquist; Leo A Barnes; Kimberly M Lutu-Fuga; Jianhua Cui; Malcolm R Wood; David A Cheresh
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

5.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors.

Authors:  Dan G Duda; Kenneth S Cohen; Sergey V Kozin; Jean Y Perentes; Dai Fukumura; David T Scadden; Rakesh K Jain
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

Review 6.  Integrins in cancer: biological implications and therapeutic opportunities.

Authors:  Jay S Desgrosellier; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Integrin affinity modulation in angiogenesis.

Authors:  Ganapati H Mahabeleshwar; Juhua Chen; Weiyi Feng; Payaningal R Somanath; Olga V Razorenova; Tatiana V Byzova
Journal:  Cell Cycle       Date:  2007-11-01       Impact factor: 4.534

8.  Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.

Authors:  Elizabeth A Morgan; Jochen G Schneider; Timothy E Baroni; Ozge Uluçkan; Emanuela Heller; Michelle A Hurchla; Hongju Deng; Desiree Floyd; Andrew Berdy; Julie L Prior; David Piwnica-Worms; Steven L Teitelbaum; F Patrick Ross; Katherine N Weilbaecher
Journal:  FASEB J       Date:  2009-11-20       Impact factor: 5.191

9.  Absence of beta3 integrin accelerates early skeletal repair.

Authors:  Diane Hu; Chuanyong Lu; Anna Sapozhnikova; Michael Barnett; Carolyn Sparrey; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-01       Impact factor: 3.494

10.  Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.

Authors:  Dong Wook Park; Kyung-Chul Choi; Colin D MacCalman; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-08-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.